Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,164,778 papers from all fields of science
Search
Sign In
Create Free Account
Timed 25-Foot Walk Functional Test
Known as:
T25FW
, T25FW1
A standardized rating scale developed to measure walking ability through gait speed. This functional test is a quantitative mobility and leg function…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
CDISC Functional Test Category Terminology
Clinical Data Interchange Standards Consortium Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Potential of Timed 25-Foot Walk Values in Predicting Maximum Walking Distance in Persons with Multiple Sclerosis.
F. Alshamrani
,
Warren Berger
,
H. Alnajashi
,
M. Payne
,
S. Morrow
International Journal of MS Care
2020
Corpus ID: 226310394
Background Expanded Disability Status Scale (EDSS) scores of 4.0 or greater are determined primarily by maximum walking distance…
Expand
2017
2017
What Variability of Treatment Effect of Fampridine Can We Expect in People with Multiple Sclerosis
K. Novotná
,
J. Preiningerova
,
L. Sobíšek
,
E. Havrdová
2017
Corpus ID: 52023142
Background: Gait impairment represents one of the most common symptoms of multiple sclerosis (MS). Fampridine is the first…
Expand
2017
2017
Avaliação Preliminar da Fampridina na Esclerose Múltipla: Para Além da Velocidade da Marcha
J. Rios
,
José Luís Cantanhede Coêlho
,
S. Rego
,
E. Afonso
2017
Corpus ID: 79674333
Introduction : The purpose of this study is to assess the impact of fampridine on walking, balance and perception of walking…
Expand
2017
2017
بررسی عوامل خطر مرتبط با حرکت در زمین خوردن بیماران مبتلا به مالتی پلاسکلروزیس: مطالعه کوهورت آینده نگرTitle: Investigation of mobility-related risk factors for falls in patients with multiple…
شیرین تجلی
2017
Corpus ID: 204054250
مقدمه:زمین خوردن یکی از مشکلات مهم مورد توجه در بیمارانmuliple sclerosis (MS) بوده و تحقیقات نشان میدهند که تقریبا بیش از 50…
Expand
2016
2016
Neurophysiological Profile, Walking Performance Tests and Self-Reported Questionnaires in Spastic Patients with MS: A Pilot Study
A. Calvi
,
M. Riz
,
+12 authors
A. Priori
2016
Corpus ID: 53647518
Nabiximols is currently being used as an add-on therapeutic option to treat severe forms of multiple sclerosis (MS) spasticity…
Expand
2015
2015
Validity of mobility measures in multiple sclerosis, according disability level: a RIMS multi-center study.
Kristien Vanoppen
,
L. Jans
2015
Corpus ID: 147873719
Background: Psychometric properties of walking measures in pwMS (persons with MS) are well investigated, however there is limited…
Expand
Review
2015
Review
2015
CP-157 Evaluation of fampridine effectiveness in adult MS patients
V. C. Turlán
,
M. Andreu
,
+4 authors
E. F. Alonso
2015
Corpus ID: 71376043
Background Multiple sclerosis (MS) is a chronic and progressive inflammatory disease that attacks the central nervous system…
Expand
2015
2015
CP-159 Assessment of effectiveness in walking ability and safety of fampridine in multiple sclerosis patients
A. Rosado
,
A. Torrents
,
A. O. Nasarre
,
Fj Farfán Sedano
2015
Corpus ID: 72791480
Background Fampridine is a voltage-dependent potassium channel blocker. It´s indicated to improve walking ability (WA) in…
Expand
2010
2010
Real maximum walking speed on short distance assessed by a corrected version of the Timed 25 Foot Walk Test (T25FW)
R. P. Ba
2010
Corpus ID: 58252826
2008
2008
New Therapies in the Pipeline for AD — What's Promising, What's Not
Tom Valeo
2008
Corpus ID: 56994460
aminopyridine) in a sustained-release (SR) form generates hope for improving gait disorders in multiple sclerosis (MS), according…
Expand